The Clorox Company
CLX
$107.94
$0.190.18%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.35% | 0.16% | -2.64% | -1.98% | 6.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.35% | 0.16% | -2.64% | -1.98% | 6.17% |
| Cost of Revenue | -8.89% | -3.28% | -7.42% | -6.05% | -1.69% |
| Gross Profit | -9.92% | 4.67% | 3.91% | 3.61% | 17.89% |
| SG&A Expenses | -8.75% | -4.48% | 0.25% | 1.16% | 5.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -50.00% | -81.25% | -70.00% | -54.76% | -14.29% |
| Total Operating Expenses | -8.98% | -4.08% | -5.42% | -4.13% | 0.36% |
| Operating Income | -11.39% | 28.52% | 16.93% | 12.99% | 56.30% |
| Income Before Tax | 84.62% | 170.85% | 161.94% | 312.10% | 261.59% |
| Income Tax Expenses | 16.48% | 139.62% | 116.67% | 179.69% | 238.46% |
| Earnings from Continuing Operations | 117.03% | 182.19% | 181.35% | 403.23% | 273.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.69% | -16.67% | -25.00% | 15.38% | 0.00% |
| Net Income | 121.57% | 189.29% | 189.17% | 471.25% | 315.12% |
| EBIT | -11.39% | 28.52% | 16.93% | 12.99% | 56.30% |
| EBITDA | -9.86% | 21.80% | 11.99% | 8.99% | 41.42% |
| EPS Basic | 123.06% | 191.19% | 189.29% | 474.73% | 314.50% |
| Normalized Basic EPS | -11.34% | 34.36% | 20.83% | 17.94% | 64.61% |
| EPS Diluted | 122.55% | 191.94% | 189.63% | 487.33% | 325.33% |
| Normalized Diluted EPS | -11.43% | 34.04% | 20.49% | 17.74% | 64.48% |
| Average Basic Shares Outstanding | -0.72% | -0.52% | -0.20% | 0.10% | 0.31% |
| Average Diluted Shares Outstanding | -0.62% | -0.29% | 0.06% | 0.22% | 0.34% |
| Dividend Per Share | 1.65% | 1.66% | 1.67% | 1.67% | 1.68% |
| Payout Ratio | -0.54% | -0.65% | -0.65% | -0.82% | -0.76% |